All In Biotech

Drug Trial Radar · NCT06397768

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL)

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 2,226 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

2,226

Actual

Start

May 13, 2024

Primary completion

Sep 18, 2025

Study completion Sep 18, 2025

Sponsor

Lead sponsor
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
Sponsor type
Industry
First posted
May 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 6 months, up to 12 months
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a Phase III, randomized, single-blind, placebo-controlled, multi-center study to be conducted in healthy infants and toddlers which will be enrolled at approximately 6 months of age (Cohort 1) and approximately 12 months of age (Cohort 2). The primary objective of the study will be to assess non-inferiority of the RSV infant and toddler (RSVt) vaccine antibody response when administered concomitantly with routine pediatric vaccines at 6 months of age (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine \[Vaxelis® or Pentacel® and Recombivax HB®\] Prevnar 20®, and RotaTeq®), and 12 months of age (M-M-R II, VARIVAX, and Prevnar 20 or per local country recommendations) compared to when administered non-concomitantly.

Conditions

  • RSV Immunization

Interventions

  • RSVt vaccineBiological

    Pharmaceutical form:Liquid for nasal spray-Route of administration:Intranasal

  • Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

  • Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

  • Hepatitis B vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

  • Streptococcus pneumoniae vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Intramuscular

  • Rotavirus vaccineBiological

    Pharmaceutical form:Oral solution-Route of administration:Oral

  • Measles, mumps, and rubella vaccineBiological

    Pharmaceutical form:Lyophilized live virus for reconstitution -Route of administration:Subcutaneous or Intramuscular

  • Varicella virus vaccineBiological

    Pharmaceutical form:Suspension for injection-Route of administration:Subcutaneous or Intramuscular

  • PlaceboBiological

    Pharmaceutical form:Liquid for nasal spray-Route of administration:Intranasal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. RSV A serum neutralizing antibody titers at 28 days post dose 2 (D85) Groups 1 and 3Time frame: Day 85
  2. RSV B serum neutralizing antibody titers at 28 days post dose 2 (D85) Groups 1 and 3Time frame: Day 85
  3. RSV A serum neutralizing antibody titers at Day 113 Groups 2 and 4Time frame: Day 113
  4. RSV B serum neutralizing antibody titers at Day 113 Groups 2 and 4Time frame: Day 113

Locations

72 sites in 3 countries. Site status is shown where the registry gives one.

  • Alabama Clinical Therapeutics - Birmingham - St. Vincent's Drive- Site Number : 8400007

    Birmingham, Alabama

  • South Alabama Medical Clinic- Site Number : 8400065

    Grand Bay, Alabama

  • MedPharmics - Mobile - Dauphin Street- Site Number : 8400017

    Mobile, Alabama

  • Northwest Arkansas Pediatric Clinic- Site Number : 8400002

    Fayetteville, Arkansas

  • Alliance Research Institute - Bell Gardens - Garfield Avenue- Site Number : 8400040

    Bell Gardens, California

  • Matrix Clinical Research - Huntington Park- Site Number : 8400018

    Huntington Park, California

  • Paradigm Clinical Research Centers- Site Number : 8400059

    La Mesa, California

  • Matrix Clinical Research - Los Angeles- Site Number : 8400008

    Los Angeles, California

  • Kaiser Permanente - Oakland Medical Center- Site Number : 8400047

    Oakland, California

  • Stanford University Medical Center CTRU - 800 Welch Road- Site Number : 8400070

    Palo Alto, California

  • Kaiser Permanente - Sierra Gardens- Site Number : 8400063

    Roseville, California

  • Kaiser Permanente - Point West Medical Offices- Site Number : 8400064

    Sacramento, California

  • Kaiser Permanente - San Jose Medical Center- Site Number : 8400060

    San Jose, California

  • Kaiser Permanente - Santa Clara Medical Center- Site Number : 8400061

    Santa Clara, California

  • Integrated Clinical Research LLC- Site Number : 8400036

    Sherman Oaks, California

  • Kaiser Permanente - Walnut Creek Medical Center- Site Number : 8400062

    Walnut Creek, California

  • Velocity Clinical Research - Washington DC- Site Number : 8400050

    Washington D.C., District of Columbia

  • Prohealth Research Center- Site Number : 8400068

    Doral, Florida

  • The Medici Medical Research- Site Number : 8400055

    Hollywood, Florida

  • Dade Research Center- Site Number : 8400014

    Miami, Florida

  • Riveldi Biomedical Research and Associates - Miami Lakes- Site Number : 8400015

    Miami Lakes, Florida

  • SEC Clinical Research - Pensacola- Site Number : 8400034

    Pensacola, Florida

  • PAS Research- Site Number : 8400005

    Tampa, Florida

  • Leavitt Women's Healthcare- Site Number : 8400009

    Idaho Falls, Idaho

  • Velocity Clinical Research - Sioux City- Site Number : 8400054

    Sioux City, Iowa

  • Alliance for Multispeciality Research - El Dorado- Site Number : 8400019

    El Dorado, Kansas

  • University of Kentucky Chandler Medical Center- Site Number : 8400051

    Lexington, Kentucky

  • Velocity Clinical Research - New Orleans- Site Number : 8400058

    New Orleans, Louisiana

  • Research Works INC- Site Number : 8400044

    New Orleans, Louisiana

  • Velocity Clinical Research - Gulfport- Site Number : 8400011

    Gulfport, Mississippi

  • QPS Bio-Kinetic Clinical Applications- Site Number : 8400046

    Springfield, Missouri

  • Boeson Research - Great Falls- Site Number : 8400041

    Great Falls, Montana

  • Boeson Research - Missoula- Site Number : 8400006

    Missoula, Montana

  • Velocity Clinical Research - Grand Island- Site Number : 8400016

    Grand Island, Nebraska

  • Midwest Childrens Health Research Institute- Site Number : 8400038

    Lincoln, Nebraska

  • Velocity Clinical Research - Omaha- Site Number : 8400001

    Omaha, Nebraska

  • PAS Research - Henderson- Site Number : 8400049

    Henderson, Nevada

  • NYU Langone Cardiothoracic Surgery Associates - Garden City- Site Number : 8400048

    Garden City, New York

  • Summerwood Pediatrics- Site Number : 8400021

    Liverpool, New York

  • SUNY Upstate Medical University - Syracuse- Site Number : 8400029

    Syracuse, New York

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.